Trinity Biotech (TRIB) FCF Margin (2009 - 2024)
Trinity Biotech recorded quarterly FCF Margin of 23.59% in Q4 2024, up 465.55% quarter-over-quarter from 4.17% in Q4 2023, and up 1942.0% year-over-year from 1.16% in Q1 2024.
Trinity Biotech's FCF Margin history runs 16 years deep, the most recent figure standing at 23.59% for Q4 2024.
- In Q4 2024, FCF Margin rose 1942.0% year-over-year to 23.59%; the TTM figure through Dec 2024 stood at 6.08% (up 1307.0% YoY), while the FY2025 annual figure was 12.95%, down 549.0% from the prior year.
- FCF Margin came in at 23.59% for Q4 2024 at Trinity Biotech, up from 4.17% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 45.3% in Q4 2020 to a low of 30.91% in Q3 2023.
- A 5-year average of 10.52% and a median of 6.35% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 3412 bps in 2020 and slumped 3725 bps in 2023, its largest moves.
- Trinity Biotech's FCF Margin stood at 45.3% in 2020, then slumped by 45 bps to 25.1% in 2021, then tumbled by 30 bps to 17.56% in 2022, then sank by 76 bps to 4.17% in 2023, then surged by 466 bps to 23.59% in 2024.
- According to Business Quant data, FCF Margin over the past three periods registered 23.59%, 4.17%, and 30.91% for Q4 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 23.59% |
| Dec 31, 2023 | 4.17% |
| Sep 30, 2023 | -30.91% |
| Dec 31, 2022 | 17.56% |
| Sep 30, 2022 | 6.35% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -8.31% |
| Dec 31, 2021 | 25.10% |
| Sep 30, 2021 | 2.04% |
| Jun 30, 2021 | 5.05% |
| Mar 31, 2021 | 23.02% |
| Dec 31, 2020 | 45.30% |
| Sep 30, 2020 | 22.40% |
| Jun 30, 2020 | 17.36% |
| Mar 31, 2020 | 5.06% |
| Dec 31, 2019 | 11.17% |
| Sep 30, 2019 | 19.58% |
| Jun 30, 2019 | 6.78% |
| Mar 31, 2019 | 12.17% |
| Dec 31, 2018 | 0.93% |
| Sep 30, 2018 | 12.37% |
| Jun 30, 2018 | 6.95% |
| Mar 31, 2018 | 2.43% |
| Dec 31, 2017 | 19.61% |
| Sep 30, 2017 | 15.56% |
| Jun 30, 2017 | 13.25% |
| Mar 31, 2017 | 0.25% |
| Dec 31, 2016 | 19.51% |
| Sep 30, 2016 | 21.27% |
| Jun 30, 2016 | 7.79% |
| Mar 31, 2016 | 7.97% |
| Dec 31, 2015 | 23.29% |
| Sep 30, 2015 | 14.30% |
| Jun 30, 2015 | 5.05% |
| Mar 31, 2015 | 7.83% |
| Dec 31, 2014 | 32.40% |
| Sep 30, 2014 | 20.36% |
| Jun 30, 2014 | 6.19% |
| Mar 31, 2014 | 3.12% |
| Dec 31, 2013 | 11.64% |
| Sep 30, 2013 | 14.65% |
| Jun 30, 2013 | 9.83% |
| Mar 31, 2013 | 12.92% |
| Dec 31, 2012 | 28.29% |
| Sep 30, 2012 | 23.46% |
| Jun 30, 2012 | 23.26% |
| Mar 31, 2012 | 16.45% |
| Dec 31, 2011 | 20.31% |
| Sep 30, 2011 | 23.68% |
| Jun 30, 2011 | 22.05% |
| Mar 31, 2011 | 30.84% |
| Dec 31, 2010 | 32.60% |
| Sep 30, 2010 | 34.36% |
| Jun 30, 2010 | 30.91% |
| Mar 31, 2010 | 25.70% |
| Dec 31, 2009 | 23.43% |
| Sep 30, 2009 | 18.03% |
| Jun 30, 2009 | 18.91% |
| Mar 31, 2009 | 15.47% |